Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.
about
Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort StudySafety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorderMaternal BMI as a predictor of methylation of obesity-related genes in saliva samples from preschool-age Hispanic children at-risk for obesityA Qualitative Study of Client-Clinician Text Exchanges in a Mobile Health Intervention for Individuals With Psychotic Disorders and Substance UseFeasibility Study of Increasing Social Support to Enhance a Healthy Lifestyle Intervention for Individuals with Serious Mental Illness.TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience.Metabolic syndrome among individuals with heroin use disorders on methadone therapy: prevalence, characteristics, and related factors.Chinese Health Improvement Profile for people with severe mental illness: A cluster-randomized, controlled trial.European Psychiatric Association (EPA) guidance on the quality of eMental health interventions in the treatment of psychotic disorders.Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis.Changes in BMI in hospitalized patients during treatment with antipsychotics, depending on gender and other factors.BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.The Utility of the Health Action Process Approach Model for Predicting Physical Activity Intentions and Behavior in SchizophreniaObesity, change of body mass index and subsequent physical and mental health functioning: a 12-year follow-up study among ageing employees.Feasibility of Behavioral Weight Loss Treatment Enhanced with Peer Support and Mobile Health Technology for Individuals with Serious Mental Illness.Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides.Visceral Fat Dysfunctions in the Rat Social Isolation Model of Psychosis.Superwellness Program: a cognitive-behavioral therapy-based group intervention to reduce weight gain in patients treated with antipsychotic drugs.The Physical Health of Individuals Receiving Antipsychotic Medication: A Qualitative Inquiry on Experiences and Needs.The effects of adjunctive intranasal oxytocin in patients with schizophrenia.Assessment of the relationship between food addiction and nutritional status in schizophrenic patients.Dietetic and educational interventions improve clinical outcomes of diabetic and obese clients with mental impairment.Association of body mass index-related single nucleotide polymorphisms with psychiatric disease and memory performance in a Japanese population.DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients.Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls.Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case-control study.4G-β-D-galactosylsucrose as a prebiotics may improve underweight in inpatients with schizophrenia.Relationship of Handgrip Strength and Body Mass Index With Cognitive Function in Patients With Schizophrenia.Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders StudyTardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysisThe effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studiesPromotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin?
P2860
Q28553358-BF7F5DC0-1454-44F4-B084-378311FC5CF1Q33878816-31DB9917-9F6B-4E65-9528-2D426B5E0A2EQ36074188-DDC7AA02-33E1-49DA-8A7A-4DC01EE4121AQ36244489-8035FF2D-2479-4C67-BF08-D287E998662CQ36813903-719CB3B5-89EF-4793-959A-E63CBE468817Q37623654-F1FAE548-3041-4A92-A24E-C6708B92FDE3Q37714911-74076A51-1FF7-48B0-99D0-2239E741EC77Q38430215-BE8545C8-24DB-419A-A381-683C29FEDA4FQ38644786-70C02D2B-BB45-48FE-896B-28DACC8A6C2CQ38645632-CE3485E1-41A8-4F6E-8E43-CC428C3533D1Q38732628-B0B32A67-B341-4E4C-BB97-96F4673E1E6EQ38749110-7913AD17-E774-4D19-84B8-24EFAD5D0059Q38789687-84537891-F86F-4E49-988B-7072B46DD24FQ38826206-93AAEC12-9B71-46C1-B101-03106375A2B6Q41245419-2654A4F7-C65F-4F6A-8F65-DDC2A6823222Q41670465-A5598925-0047-4B6E-A34E-60952CC0E481Q41864375-A7A1E9F2-6CE0-4A57-8631-F5EE414BEBC5Q42280452-F40FF333-FC9E-4603-992C-C1084210A7A2Q45781814-6E69CD5B-15BF-41DD-986F-C40CB497CAC7Q47228167-9F784D88-0960-46EB-A004-991072A1BF91Q47555927-52DF3CA8-3A8A-49B9-875D-04D6523145A6Q47580425-5A69C64A-3B3E-4394-A89B-A2CDCCE23BFFQ47587248-7A1B2B2B-FB2C-43B3-864C-24298CD1D4F0Q47663548-3B5BA89C-6EF1-4344-B9C9-B1E2AE070D6DQ47859658-33F5A3B1-9D73-4F20-A2FD-EF5353815F9CQ48263449-CFF8D5E3-CD2C-4F6A-94FE-7022D03C8D9BQ50567316-7D70B4A8-D1F4-4B77-B5E0-D9A77D022FD5Q55003650-AFDC05D8-7925-45BD-9279-8C1A5E2A6245Q55129217-7E2665A4-8B18-4570-B515-3D3374A2DBCBQ55246989-F8C6BB95-11B2-4188-9EFC-00B637529562Q57164581-D19E3F83-995E-4DA1-B679-AEB231C58A00Q58760344-6C29454E-D994-4423-9553-31240EFCA6D0Q58802216-1A70CB1B-E1D8-4895-9422-294A4A97811CQ58809455-5D6FAD0F-2E0F-444A-8C4C-E35DB82F6DDF
P2860
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.
@en
type
label
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.
@en
prefLabel
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.
@en
P2093
P2860
P921
P356
P1476
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.
@en
P2093
P2860
P304
P356
10.1111/ACPS.12445
P407
P577
2015-05-27T00:00:00Z